INDP · Forms 3, 4, 5
Insider trades at Indaptus Therapeutics, Inc.
No open-market insider buys or sells at Indaptus Therapeutics, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Indaptus Therapeutics, Inc. (INDP) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Indaptus Therapeutics, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Qinglai Lu | Director | Became an insider (Form 3) | Form 3 | ||||
| Yun Yao | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| SINO LION VENTURES Ltd | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| Junyi Dai | Chief Executive Officer | Became an insider (Form 3) | Form 3 | ||||
| David E. Lazar | Director | Options or other derivatives | Form 4 | ||||
| Jerome D Jabbour | Director | Options or other derivatives | Form 4 | ||||
| Jerome D Jabbour | Director | Became an insider (Form 3) | Form 3 | ||||
| Matthew Charles McMurdo | Director | Became an insider (Form 3) | Form 3 | ||||
| Jeffrey A Meckler | Co-Chief Executive Officer | Options or other derivatives | Form 4 | ||||
| Avraham Ben-Tzvi | Director | Award | 25,000 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.